The organization catapulted onto the
global stage with a standout IPO during
the pandemic. Today, the brand identity
continues to evolve and resonate
worldwide as the ADCT clinical pipeline
gains critical momentum. Their
breakthroughs in Antibody-Drug
Conjugates (ADCs) are transforming
oncology—turning the tide on survival
rates for cancer patients across
the globe.
The organization catapulted onto the global stage with a standout IPO during the pandemic. Today, the brand identity continues to evolve and resonate worldwide as the ADCT clinical pipeline gains critical momentum. Their breakthroughs in Antibody-Drug Conjugates (ADCs) are transforming oncology—turning the tide on survival rates for cancer patients across the globe.
ADC Therapeutics–
Corporate Brand Launch
ADC Therapeutics–
Corporate Brand Launch
Working as lead creative in a small alliance to align stakeholders and create a brand identity for ADC Therapeutics.
Developing an ownable US-facing corporate presence for a growing global oncology biotech organization.
Challenge
Challenge
ADCT, a company with roots in Switzerland, had a robust pipeline, however it was lacking
sophistication in its marketing promotion and had little presence in the U.S. The road to
demonstrated leadership of the technology began with clinical trail branding.
Approach
Bring forward the core of ADCT’s namesake, which is the Antibody-Drug Conjugate technology,
by designing a contemporary creative platform that weds their technology to the notion of always ADVANCING.
ADC needed brand momentum for investor attention as their pipeline was fast-tracking to launch.
Bring forward the core of ADCT’s
namesake, which is the
Antibody-Drug Conjugate technology,
by designing a contemporary creative
platform that weds their technology
to the notion of always ADVANCING.
ADC needed brand momentum for
investor attention as their pipeline
was fast-tracking to launch.
Bring forward the core of ADCT’s namesake, which is the
Antibody-Drug Conjugate technology, by designing a contemporary creative platform that weds their technology
to the notion of always ADVANCING. ADC needed brand momentum for investor attention as their pipeline
was fast-tracking to launch.
Results
The organization catapulted onto the global stage with a standout IPO during the pandemic.
Today, the brand identity continues to evolve and resonate worldwide as the ADCT clinical pipeline gains critical
momentum. Their breakthroughs in Antibody-Drug Conjugates (ADCs) are transforming oncology—
turning the tide on survival rates for cancer patients across the globe.
ADC Therapeutics–Corporate Brand Launch
Working as lead creative in a small
alliance to align stakeholders and
create a brand identity for ADC
Therapeutics. Developing an ownable
US-facing corporate presence for a
growing global oncology biotech
organization.
Working as lead creative in a small alliance to align stakeholders and create a brand identity for ADC Therapeutics. Developing an ownable US-facing corporate presence for a growing global oncology biotech organization.
ADCT, a company with roots in
Switzerland, had a robust pipeline,
however it was lacking sophistication
in its marketing promotion and had
little presence in the U.S. The road to
demonstrated leadership of the
technology began with clinical trail
branding.
ADCT, a company with roots in Switzerland, had a robust pipeline, however it was lacking sophistication
in its marketing promotion and had little presence in the U.S. The road to demonstrated leadership of the technology began with clinical trail branding.
The organization catapulted onto the
global stage with a standout IPO during
the pandemic. Today, the brand identity
continues to evolve and resonate
worldwide as the ADCT clinical pipeline
gains critical momentum. Their
breakthroughs in Antibody-Drug
Conjugates (ADCs) are transforming
oncology—turning the tide on survival
rates for cancer patients across
the globe.